Geron Corporation

NASDAQ:GERN

Biotechnology

Healthcare
$0.91 +4.07%

+$0.05 today

Market cap
$588.19M
Beta
0.60
P/E (TTM)
-12.3
EPS (TTM)
-$0.10
52W Low $1.04High $2.01

Volume 19.64M

Average 16.28M

Cash Flow

Check whether earnings turn into cash.

Operating Cash Flow

-$111.04M

FY 2025 · Annual

Investing Cash Flow

$107.25M

FY 2025 · Annual

Financing Cash Flow

$2.27M

FY 2025 · Annual

-99.3% YoY

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income(116.11M)(141.9M)(184.13M)(174.57M)(85.78M)
Depreciation & Amortization783K868K1.03M1.22M1.2M
Deferred Income Tax191K0000
Stock-Based Compensation8.08M8M19.35M31.32M88K
Change in Working Capital10.52M5.03M6.06M(68.41M)(68.54M)
Accounts Receivables(1.04M)(1.38M)1.49M(36.89M)(377K)
Inventory1.04M1.38M0(37.97M)(77.92M)
Accounts Payables(232K)3.5M(4.03M)2.44M2.66M
Other Working Capital10.75M1.52M8.6M4.02M7.1M
Other Non-Cash Items984K626K(10.06M)(8.18M)41.99M
Operating Cash Flow(95.56M)(127.38M)(167.74M)(218.62M)(111.04M)
Capital Expenditures(207K)(431K)(830K)(680K)(49K)
Acquisitions (Net)1.59M(1.23M)179.49M00
Purchases of Investments(177.43M)(258.01M)(475.59M)(476.93M)(304.42M)
Sales of Investments249.59M320.51M296.1M371.61M411.72M
Other Investing Activities(1.59M)1.23M(179.49M)00
Investing Cash Flow71.95M62.07M(180.32M)(106M)107.25M
Debt Repayment24.9M029.7M34.57M0
Common Stock Issued20.39M69.92M213.34M140.73M2.27M
Common Stock Repurchased00000
Dividends Paid00000
Other Financing Activities3.28M17.35M118.98M159.08M0
Financing Cash Flow48.56M87.26M362.02M334.37M2.27M
Effect of Forex Changes022K(27K)(12K)87K
Net Change in Cash24.95M21.97M13.93M9.74M(1.44M)
Free Cash Flow(95.76M)(127.81M)(168.57M)(219.3M)(111.09M)

Free Cash Flow

Net Income to FCF bridge

FY2025

= Net Income-$85.8M
+ D&A$1.2M
+ Stock-Based Comp$88.0K
+ Deferred Tax$0
- Working Capital-$68.5M
+ Other Non-Cash$42.0M
= Operating Cash Flow-$111.0M
- Capex-$49.0K
= Free Cash Flow-$111.1M

Analysis

FY2025 free cash flow is -$111.1M. FCF conversion is 129.5% of net income. Operating cash flow was -$111.0M, with capex of -$49.0K. The largest bridge item is Working Capital at -$68.5M.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
SC 13GSC 13G filingNov 10, 2026
8-KCurrent reportNov 4, 2026
10-QQuarterly reportNov 4, 2026
8-KCurrent reportOct 28, 2026
4Statement of changes in beneficial ownershipOct 1, 2026

Does GERN generate free cash flow?

Geron Corporation (GERN) generated -$111.09M of free cash flow in fiscal 2025.

How much operating cash flow does GERN produce?

Operating cash flow was -$111.04M, before capital expenditures of $49,000.00.